Form D · Biotechnology
Cocoon Biotech Inc.
Mansfield, MA · CIK 0001611264
Offering snapshot reported Dec 13, 2021 · SEC filing
- Reported sold
- $385K Offering amount: $1000K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 2, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 13, 2021 | Initial | $385,163 | No comparison | 6 | SEC filing |
| Oct 6, 2020 | Initial | $865,408 | No comparison | 4 | SEC filing |
| Nov 1, 2019 | Amendment | $4,495,285 | $3,740,285vs Mar 1, 2017 | 32 | SEC filing |
| Mar 1, 2017 | Initial | $755,000 | No comparison | 14 | SEC filing |
| Oct 6, 2015 | Initial | $1,809,946 | No comparison | 18 | SEC filing |
| Jun 19, 2014 | Initial | $200,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-424719
Source: Form D, filed Dec 13, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Grace Colon | Director |
| Annalisa Jenkins | Director |
| Charles Koppel | Director |
| Mary Thistle | Director |
| Ailis Tweed Kent | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
241 Francis Avenue
Mansfield, MA, 02048
Mansfield, MA, 02048